CRWV Form 4: Nitin Agrawal Disposes 38.4k Class A Shares via 10b5-1
Rhea-AI Filing Summary
Nitin Agrawal, Chief Financial Officer of CoreWeave, Inc. (CRWV), reported multiple sales of Class A common stock on 09/16/2025 executed under a Rule 10b5-1 trading plan adopted May 22, 2025. Collectively, the reported transactions disposed of 38,422 shares across several tranches at weighted-average prices ranging approximately from $115.41 to $125.31, leaving the reporting person with 145,588 shares held directly. The filing also discloses 115,905 shares held directly by the reporting person’s spouse and 57,952 shares held by the Yosemite 2025 GRAT, of which the reporting person is sole trustee and beneficiary. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating pre-authorized, compliant disposition of shares
- Clear disclosure of related-party holdings (spouse and Yosemite 2025 GRAT), enhancing transparency
Negative
- Insider disposed of 38,422 Class A shares, reducing direct beneficial ownership to 145,588 shares
- Sales span price ranges from $115.41 to $125.31, which may reflect substantial insider liquidity on the reported date
Insights
TL;DR: Routine insider sales under a pre-established 10b5-1 plan totaling 38,422 shares; no derivative activity reported.
The Form 4 discloses multiple systematic sales executed the same day pursuant to a 10b5-1 plan, indicating pre-authorized disposition rather than ad-hoc selling. Sales reduced direct beneficial ownership to 145,588 shares while related-party holdings remain material (spouse and GRAT). There are no derivative transactions reported, so dilution from options or conversions is not indicated in this filing. For investors, this is disclosure of insider liquidity but does not by itself reveal company operational changes.
TL;DR: Good compliance practice—insider used a documented 10b5-1 plan; disclosure shows related-party holdings which improves transparency.
The filing clearly states the use of a Rule 10b5-1 plan adopted May 22, 2025, and provides weighted-average price ranges in explanatory footnotes, meeting disclosure norms. The reporting of spouse-held shares and a GRAT underscores transparency about indirect holdings. No amendments to prior filings are indicated. This is a standard governance disclosure of permitted insider sales rather than an extraordinary event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 2,800 | $116.0188 | $325K |
| Sale | Class A Common Stock | 8,977 | $116.9067 | $1.05M |
| Sale | Class A Common Stock | 13,140 | $118.0254 | $1.55M |
| Sale | Class A Common Stock | 9,118 | $118.7926 | $1.08M |
| Sale | Class A Common Stock | 1,590 | $119.901 | $191K |
| Sale | Class A Common Stock | 1,100 | $120.8227 | $133K |
| Sale | Class A Common Stock | 1,000 | $122.214 | $122K |
| Sale | Class A Common Stock | 398 | $123.4797 | $49K |
| Sale | Class A Common Stock | 199 | $124.4339 | $25K |
| Sale | Class A Common Stock | 100 | $125.31 | $13K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.41 to $116.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 3 through 10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.42 to $117.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.44 to $118.43, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.44 to $119.41, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.45 to $120.44, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.27, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.74 to $122.70, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.12 to $123.79, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.21 to $124.66, inclusive. The reported securities are directly held by the reporting person's spouse. The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
